Prof. Dr. Philipp Paprottka

Academic Career and Research Areas

Philipp M. Paprottka and his team develop new techniques and medical devices for interventional radiology in close cooperation with basic subjects such as physics and engineering.

A key focus of his research is on preclinical, clinical and multicenter studies of oncological therapies. His research activities also include the implementation and evaluation of innovative teaching concepts for conveying manual skills in interventional radiology, with the long-term objective of establishing a future "simulator culture" at German universities.

Paprottka studied and completed his doctorate at the University of Münster. In 2008, he moved to the Ludwig-Maximilians-Universität (LMU) München, where he was head of Interventional Radiology at the University Campus Grosshadern. In February 2018, Paprottka was appointed as adjunct professor at LMU Munich and in April 2018 he was appointed as Professor of Interventional Radiology at the Technical University of Munich (TUM). Paprottka has been an elected member of the executive board of the German Society for Interventional Radiology since May 2018.


    • Young investigator award of the German Society for Clinical Microcirculation and Hemorheology (2012)
    • First poster prize of the Austrian-Bavarian Radiology Congress (2010)
    • Young investigator award of the German Society for Clinical Microcirculation and Hemorheology (2010)

    Ingrisch M, Schöppe F, Paprottka K, Fabritius M, Strobl FF, De Toni EN, Ilhan H, Todica A, Michl M, Paprottka PM.: "Prediction of 90Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests". Journal of Nuclear Medicine. 2018; 59(5):769-773.


    Paprottka KJ, Todica A, Ilhan H, Rübenthaler J, Schoeppe F, Michl M, Heinemann V, Bartenstein P, Reiser MF, Paprottka PM: "Evaluation of Visualization Using a 50/50 (Contrast Media/Glucose 5% Solution) Technique for Radioembolization as an Alternative to a Standard Sandwich Technique“. CardioVascular and  Interventional Radiology. 2017; 40(11):1740-1747.


    Paprottka KJ, Schoeppe F, Ingrisch M, Rübenthaler J, Sommer NN, De Toni E, Ilhan H, Zacherl M, Todica A, Paprottka PM: "Pre-therapeutic factors for predicting survival after radioembolization: a single-center experience in 389 patients". European Journal of Nuclear Medicine and Molecular Imaging. 2017; 44(7):1185-1193.


    Jakobs TF, Paprottka KJ, Raeßler F, Strobl F, Lehner S, Ilhan H, Trumm CG, Fendler WP, Sommer W, Paprottka PM: "Robust evidence for long-term survival with 90Y radioembolization in chemorefractory liver-predominant metastatic colorectal cancer". European Radiology. 2017; 27(1):113-119.


    Paprottka KJ, Lehner S, Fendler WP, Ilhan H, Rominger A, Sommer W, Clevert DA, Op den Winkel M, Heinemann V, Paprottka PM: "Reduced Periprocedural Analgesia After Replacement of Water for Injection with Glucose 5% Solution as the Infusion Medium for 90Y-Resin Microspheres." Journal of  Nuclear Medicine. 2016; 57(11):1679-1684.